192 related articles for article (PubMed ID: 27632932)
21. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
22. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
[TBL] [Abstract][Full Text] [Related]
23. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
24. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
25. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
Gobe GC; Ng KL; Small DM; Vesey DA; Johnson DW; Samaratunga H; Oliver K; Wood S; Barclay JL; Rajandram R; Li L; Morais C
Biochem Biophys Res Commun; 2016 Apr; 473(1):47-53. PubMed ID: 26995091
[TBL] [Abstract][Full Text] [Related]
26. Aqueous Extract of Anticancer Drug CRUEL Herbomineral Formulation Capsules Exerts Anti-proliferative Effects in Renal Cell Carcinoma Cell Lines.
Verma SP; Sisoudiya S; Das P
Asian Pac J Cancer Prev; 2015; 16(18):8419-23. PubMed ID: 26745095
[TBL] [Abstract][Full Text] [Related]
27. PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.
Zhan B; Kong C; Guo K; Zhang Z
Tumour Biol; 2013 Jun; 34(3):1759-66. PubMed ID: 23526078
[TBL] [Abstract][Full Text] [Related]
28. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
[TBL] [Abstract][Full Text] [Related]
29. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Jungwirth A; Schally AV; Pinski J; Groot K; Armatis P; Halmos G
Proc Natl Acad Sci U S A; 1997 May; 94(11):5810-3. PubMed ID: 9159156
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21‑cyclin E2‑Bax/caspase-3 signaling pathway.
Liu Z; Lu Y; Xiao Y; Lu Y
Oncol Rep; 2017 Mar; 37(3):1437-1444. PubMed ID: 28184919
[TBL] [Abstract][Full Text] [Related]
32. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
33. The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma.
Huang B; Cao K; Li X; Guo S; Mao X; Wang Z; Zhuang J; Pan J; Mo C; Chen J; Qiu S
J Exp Clin Cancer Res; 2011 Sep; 30(1):88. PubMed ID: 21955404
[TBL] [Abstract][Full Text] [Related]
34. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
[TBL] [Abstract][Full Text] [Related]
35. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI
J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540
[TBL] [Abstract][Full Text] [Related]
37. SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.
Cheng Y; Wang X; Wang P; Li T; Hu F; Liu Q; Yang F; Wang J; Xu T; Han W
Tumour Biol; 2016 Jul; 37(7):9919-30. PubMed ID: 26815503
[TBL] [Abstract][Full Text] [Related]
38. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
Morais C; Pat B; Gobe G; Johnson DW; Healy H
Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
[TBL] [Abstract][Full Text] [Related]
40. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
Mizumoto A; Yamamoto K; Nakayama Y; Takara K; Nakagawa T; Hirano T; Hirai M
J Pharmacol Exp Ther; 2015 Nov; 355(2):152-8. PubMed ID: 26306766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]